Veraxa Biotech Holding AG VRXA
NASDAQ VRXA
$1.89 +0.03 (+1.61%)
At close: Aug 20, 2026 · 4:00 PM EDT

Veraxa Biotech Holding AG (VRXA) Cash from Operations (2025)

Veraxa Biotech Holding AG (VRXA) posted quarterly Cash from Operations of 1251.17 for Q4 2025.

Veraxa Biotech Holding AG (VRXA) Cash from Operations (2025) Analysis & Trends

Veraxa Biotech Holding AG (VRXA) has reported Cash from Operations for 1 consecutive years, with 1251.17 the latest figure, recorded in Q4 2025.

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

Historic Data

Download Data
DateValue
Dec 31, 2025 1,251.17
Dec 31, 2025 1,251.17